ipilimumab,nivolumab,cabozantinib
exelixis,bms
['so proud', 'cosmic 313']
 wow ! blown away by the amazing &amp; well balanced discussion on the cosmic 313 study by the terrific . so proud to call him a great friend &amp; colleague. it was like listening to a podcast of an editorial #esmo22 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.